The Ferring Company sold out of secretin by October 16th. Parents, doctors, and university medical centers are scrambling to purchase new supplies as more secretin trickles into the pipeline. Efforts are underway to increase the supply. The good news is that confirmatory evidence of the power of secretin keeps coming. I want to eat.
Most cases are much less dramatic, but the autism world is excited, and for good reason.
Dr. Duane Alexander, Director of the National Institute of Child Health and Development, and his assistant for autism affairs, Dr. Marie Bristol-Power, have been extremely helpful and supportive. Following is the abstract of the presentation I gave at the December 14th meeting arranged by Dr. Bristol-Power to expedite the clinical trials the FDA requires. Our primary role is to identify promising approaches to treatment and to accelerate the process of evaluating and implementing the best of these approaches. The use of secretin appears to be the most promising treatment yet discovered for the treatment of autism. ARI has set itself the task of obtaining, as quickly as possible, at least tentative answers to the questions of greatest interest to parents and clinicians, and to researchers embarking on clinical trials.